The University of Southampton
University of Southampton Institutional Repository

A randomised multi-arm, open label trial of nasal sprays and a behavioural intervention for acute respiratory illness in primary care: a randomised, controlled, open-label, parallel-group trial

A randomised multi-arm, open label trial of nasal sprays and a behavioural intervention for acute respiratory illness in primary care: a randomised, controlled, open-label, parallel-group trial
A randomised multi-arm, open label trial of nasal sprays and a behavioural intervention for acute respiratory illness in primary care: a randomised, controlled, open-label, parallel-group trial
Background: limited evidence suggests that nasal sprays, or physical activity and stress-management, could limit respiratory infections. This study aimed to assess the impact on respiratory illnesses from nasal sprays or promoting physical activity and stress-management.

Methods: 13799 participants aged >=18, from 332 GP practices, with co-morbidities and/or >=3 self-reported recurrent illnesses , were randomised by online software to: i) usual care (n=3451) ii) gel-based spray (n=3448) (2 sprays per nostril, up to 6 times/day) iii) saline spray (n=3450) (same dosing), or iv) a brief behavioural website promoting physical activity and stress-management (n=3450). The sprays were relabelled. Primary outcome: respiratory illness days over 6 months. Harms: side effects, antibiotic use.

Findings: the usual care group (n=2983 analysed) had a mean of 8 self-reported illness days which was reduced in both spray groups (gel-based (n=2935) 6.5 days adjusted incidence rate ratio (IRR) 0.82, 99% CIs 0.76, 0.90, p<0.0001), Saline (n=2967) 6.4 days (IRR 0.81; 0.74,0.88, p<0.0001), behavioural website (n=2727) 7.4 days (0.97; 0.91, 1.04), p=0.46); for those reporting an illness it was 15,12,11.8 and 14 days respectively. Headache was more common with the gel-based spray (7.8%(199/2556) vs 4.8% (123/2547) usual care; risk ratio 1.61, 95% CIs 1.30 to 1.99, p<0.0001), but antibiotic use was lower for all interventions (IRRs (95% CIs) respectively 0.65 (0.50 to 0.84;p=0.001), 0.69 (0.45,0.88;p=0.003), 0.74 (0.57 to 0.94;p=0.02)).

Interpretation: advice to use either nasal spray at the first sign of an RTI reduced illness duration and both sprays and the behavioural website reduced antibiotic use.

Prospective registration: ISRCTN (17936080; 30/10/2020) 
primary care, respiratory
2213-2600
Little, Paul
1bf2d1f7-200c-47a5-ab16-fe5a8756a777
Vennik, Jane
6ee78166-5a7a-433b-87fc-018771f20b19
Rumsby, Kate
2002ee8a-32ac-4119-869d-ed35164c3b51
Becque, Taeko
ecd1b4d5-4db8-4442-81c2-04aa291cf2fd
Moore, Michael
1be81dad-7120-45f0-bbed-f3b0cc0cfe99
Francis, Nick
9b610883-605c-4fee-871d-defaa86ccf8e
Bradbury, Katherine
87fce0b9-d9c5-42b4-b041-bffeb4430863
Greenwell, Kate
4bac64bd-059f-4d7d-90d3-5c0bccb7ffb2
Dennison, Laura
15c399cb-9a81-4948-8906-21944c033c20
Holt, Sian
b6977ce7-16bf-4dde-92f4-18abe85ad093
Denison-Day, James
49c0d012-eadc-44eb-b06c-da7714be145a
Ainsworth, Ben
b02d78c3-aa8b-462d-a534-31f1bf164f81
Raftery, James
27c2661d-6c4f-448a-bf36-9a89ec72bd6b
Thomas, Tammy
742fc3b2-61cb-4f87-8466-afa31b3c8d8e
Williams, Sam
7cec7c3e-7247-473e-8121-f26b625893e1
Sach, Tracey
5c09256f-ebed-4d14-853a-181f6c92d6f2
Miller, Sascha
448d724f-ce7d-4e8e-9ff1-e0255e995c77
Yardley, Lucy
64be42c4-511d-484d-abaa-f8813452a22e
Geraghty, Adam W.A.
2c6549fe-9868-4806-b65a-21881c1930af
et al.
Little, Paul
1bf2d1f7-200c-47a5-ab16-fe5a8756a777
Vennik, Jane
6ee78166-5a7a-433b-87fc-018771f20b19
Rumsby, Kate
2002ee8a-32ac-4119-869d-ed35164c3b51
Becque, Taeko
ecd1b4d5-4db8-4442-81c2-04aa291cf2fd
Moore, Michael
1be81dad-7120-45f0-bbed-f3b0cc0cfe99
Francis, Nick
9b610883-605c-4fee-871d-defaa86ccf8e
Bradbury, Katherine
87fce0b9-d9c5-42b4-b041-bffeb4430863
Greenwell, Kate
4bac64bd-059f-4d7d-90d3-5c0bccb7ffb2
Dennison, Laura
15c399cb-9a81-4948-8906-21944c033c20
Holt, Sian
b6977ce7-16bf-4dde-92f4-18abe85ad093
Denison-Day, James
49c0d012-eadc-44eb-b06c-da7714be145a
Ainsworth, Ben
b02d78c3-aa8b-462d-a534-31f1bf164f81
Raftery, James
27c2661d-6c4f-448a-bf36-9a89ec72bd6b
Thomas, Tammy
742fc3b2-61cb-4f87-8466-afa31b3c8d8e
Williams, Sam
7cec7c3e-7247-473e-8121-f26b625893e1
Sach, Tracey
5c09256f-ebed-4d14-853a-181f6c92d6f2
Miller, Sascha
448d724f-ce7d-4e8e-9ff1-e0255e995c77
Yardley, Lucy
64be42c4-511d-484d-abaa-f8813452a22e
Geraghty, Adam W.A.
2c6549fe-9868-4806-b65a-21881c1930af

Little, Paul, Vennik, Jane and Rumsby, Kate , et al. (2024) A randomised multi-arm, open label trial of nasal sprays and a behavioural intervention for acute respiratory illness in primary care: a randomised, controlled, open-label, parallel-group trial. The Lancet Respiratory Medicine. (doi:10.1016/S2213-2600(24)00140-1).

Record type: Article

Abstract

Background: limited evidence suggests that nasal sprays, or physical activity and stress-management, could limit respiratory infections. This study aimed to assess the impact on respiratory illnesses from nasal sprays or promoting physical activity and stress-management.

Methods: 13799 participants aged >=18, from 332 GP practices, with co-morbidities and/or >=3 self-reported recurrent illnesses , were randomised by online software to: i) usual care (n=3451) ii) gel-based spray (n=3448) (2 sprays per nostril, up to 6 times/day) iii) saline spray (n=3450) (same dosing), or iv) a brief behavioural website promoting physical activity and stress-management (n=3450). The sprays were relabelled. Primary outcome: respiratory illness days over 6 months. Harms: side effects, antibiotic use.

Findings: the usual care group (n=2983 analysed) had a mean of 8 self-reported illness days which was reduced in both spray groups (gel-based (n=2935) 6.5 days adjusted incidence rate ratio (IRR) 0.82, 99% CIs 0.76, 0.90, p<0.0001), Saline (n=2967) 6.4 days (IRR 0.81; 0.74,0.88, p<0.0001), behavioural website (n=2727) 7.4 days (0.97; 0.91, 1.04), p=0.46); for those reporting an illness it was 15,12,11.8 and 14 days respectively. Headache was more common with the gel-based spray (7.8%(199/2556) vs 4.8% (123/2547) usual care; risk ratio 1.61, 95% CIs 1.30 to 1.99, p<0.0001), but antibiotic use was lower for all interventions (IRRs (95% CIs) respectively 0.65 (0.50 to 0.84;p=0.001), 0.69 (0.45,0.88;p=0.003), 0.74 (0.57 to 0.94;p=0.02)).

Interpretation: advice to use either nasal spray at the first sign of an RTI reduced illness duration and both sprays and the behavioural website reduced antibiotic use.

Prospective registration: ISRCTN (17936080; 30/10/2020) 

Text
Lancetpaperrevisedcleanmaintext-1 - Accepted Manuscript
Available under License Creative Commons Attribution.
Download (344kB)
Text
1-s2.0-S2213260024001401-main - Proof
Available under License Creative Commons Attribution.
Download (300kB)
Text
appendixv4-3
Available under License Creative Commons Attribution.
Download (345kB)

More information

Accepted/In Press date: 14 June 2024
e-pub ahead of print date: 11 July 2024
Keywords: primary care, respiratory

Identifiers

Local EPrints ID: 492181
URI: http://eprints.soton.ac.uk/id/eprint/492181
ISSN: 2213-2600
PURE UUID: 15e98512-51dd-4741-afce-7de385485c5e
ORCID for Paul Little: ORCID iD orcid.org/0000-0003-3664-1873
ORCID for Jane Vennik: ORCID iD orcid.org/0000-0003-4602-9805
ORCID for Kate Rumsby: ORCID iD orcid.org/0000-0002-8573-3718
ORCID for Taeko Becque: ORCID iD orcid.org/0000-0002-0362-3794
ORCID for Michael Moore: ORCID iD orcid.org/0000-0002-5127-4509
ORCID for Nick Francis: ORCID iD orcid.org/0000-0001-8939-7312
ORCID for Katherine Bradbury: ORCID iD orcid.org/0000-0001-5513-7571
ORCID for Kate Greenwell: ORCID iD orcid.org/0000-0002-3662-1488
ORCID for Laura Dennison: ORCID iD orcid.org/0000-0003-0122-6610
ORCID for Sian Holt: ORCID iD orcid.org/0000-0001-5448-3499
ORCID for Ben Ainsworth: ORCID iD orcid.org/0000-0002-5098-1092
ORCID for Sam Williams: ORCID iD orcid.org/0000-0001-9505-6485
ORCID for Tracey Sach: ORCID iD orcid.org/0000-0002-8098-9220
ORCID for Sascha Miller: ORCID iD orcid.org/0000-0002-1949-5774
ORCID for Lucy Yardley: ORCID iD orcid.org/0000-0002-3853-883X
ORCID for Adam W.A. Geraghty: ORCID iD orcid.org/0000-0001-7984-8351

Catalogue record

Date deposited: 19 Jul 2024 16:36
Last modified: 20 Jul 2024 02:11

Export record

Altmetrics

Contributors

Author: Paul Little ORCID iD
Author: Jane Vennik ORCID iD
Author: Kate Rumsby ORCID iD
Author: Taeko Becque ORCID iD
Author: Michael Moore ORCID iD
Author: Nick Francis ORCID iD
Author: Kate Greenwell ORCID iD
Author: Laura Dennison ORCID iD
Author: Sian Holt ORCID iD
Author: Ben Ainsworth ORCID iD
Author: James Raftery
Author: Tammy Thomas
Author: Sam Williams ORCID iD
Author: Tracey Sach ORCID iD
Author: Sascha Miller ORCID iD
Author: Lucy Yardley ORCID iD
Corporate Author: et al.

Download statistics

Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.

View more statistics

Atom RSS 1.0 RSS 2.0

Contact ePrints Soton: eprints@soton.ac.uk

ePrints Soton supports OAI 2.0 with a base URL of http://eprints.soton.ac.uk/cgi/oai2

This repository has been built using EPrints software, developed at the University of Southampton, but available to everyone to use.

We use cookies to ensure that we give you the best experience on our website. If you continue without changing your settings, we will assume that you are happy to receive cookies on the University of Southampton website.

×